Biologic markers and antidepressant response.
The use of biologic markers to predict antidepressant treatment response may lead to more rational selection of specific drugs for individual patients. Several biologic markers being developed as potential predictors of antidepressant treatment response are reviewed. Although research in this area is primarily concerned with predicting response to drug treatment, it may also prove useful in predicting which depressed patients may respond best to psychological treatments or combinations of biologic and psychologic treatments.
D000928:Antidepressive Agents / Q000627:therapeutic use*; D001692:Biological Transport; D001714:Bipolar Disorder / Q000097:blood / Q000175:diagnosis / Q000628:therapy; D003866:Depressive Disorder / Q000097:blood / Q000175:diagnosis* / Q000628:therapy; D003907:Dexamethasone; D003913:Dextroamphetamine; D003937:Diagnosis, Differential; D004912:Erythrocytes / Q000378:metabolism; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008094:Lithium / Q000097:blood / Q000378:metabolism; D008734:Methoxyhydroxyphenylglycol / Q000652:urine; D011613:Psychotherapy
D000928:Antidepressive Agents; D008734:Methoxyhydroxyphenylglycol; D003907:Dexamethasone; D008094:Lithium; D003913:Dextroamphetamine; D006854:Hydrocortisone